Quality Control for AD Biomarkers

Corresponding Organization :

Other organizations : University of Gothenburg, Sahlgrenska University Hospital, Tohoku University, Policlinico Tor Vergata, Centro San Giovanni di Dio Fatebenefratelli, Amsterdam UMC Location VUmc, Alzheimer's Association, New York State Office for People With Developmental Disabilities, Fujirebio (Belgium), University of Perugia, Worldwide Clinical Trials (United States), Karolinska University Hospital, Hope Center for Neurological Disorders, Universidade de São Paulo, University of California, San Diego, University of Milan, Goethe University Frankfurt, Aarhus University Hospital, Klinik und Poliklinik für Neurologie, University of Bonn, Massachusetts General Hospital, MaineGeneral Medical Center, University of Eastern Finland, Kuopio University Hospital, Innsbruck Medical University, University of Tübingen, Hertie Institute for Clinical Brain Research, German Center for Neurodegenerative Diseases, Heidelberg University, Eginition Hospital, National and Kapodistrian University of Athens, Janssen (United States), University of Szeged, Edith Cowan University, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Universitätsklinikum Erlangen, University of Melbourne, Mental Health Research Institute, Janssen (Belgium), Johns Hopkins University, Johns Hopkins Medicine, University of Washington, Universität Ulm, Mayo Clinic in Florida, Radboud University Nijmegen, Radboud University Medical Center, Fondazione Santa Lucia, Istituti di Ricovero e Cura a Carattere Scientifico, University of Pennsylvania, Akershus University Hospital, University of Göttingen, Meso Scale Discovery (United States)